Chinese IPO

Shanghai Pharma braves weak market with $2.2 billion IPO

Shanghai Pharma's IPO beats the odds to find good demand in difficult market conditions.
<div style="text-align: left;"> China's healthcare market has doubled during the past five years</div>
<div style="text-align: left;"> China's healthcare market has doubled during the past five years</div>
May 04, 2011

Shanghai Pharmaceuticals Holding kicked off bookbuilding for a $2.2 billion (HK$17.27 billion) initial public offering in Hong Kong yesterday, despite a lukewarm primary market.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media